Importantly, the pricing of poultry medicines such as Respiron is not simply a matter of profit margins for pharmaceutical companies. It also encompasses ethical considerations regarding animal welfare and public health. By ensuring that poultry producers have access to effective respiratory treatments at reasonable prices, the industry can maintain high standards of animal care. This, in turn, helps mitigate the risk of zoonotic diseases, which can be transmitted from animals to humans, posing public health challenges.